What question did this study set out to answer?

This research aims to assess the role of metabolic parameters in predicting treatment response and prognosis in Hodgkin lymphoma.

February 19, 2026Turkish Journal of Hematology0 citationsOpen Access

Role of ¹⁸F-FDG PET Metabolic Parameters in Treatment Response Evaluation and Prognostic Assessment of Hodgkin Lymphoma: A Retrospective Analysis

HUHatice Uysal AGAziz Gültekin NGNil Güler

Key Points

This research aims to assess the role of metabolic parameters in predicting treatment response and prognosis in Hodgkin lymphoma.
Conducted a retrospective analysis of Hodgkin lymphoma cases
Evaluated baseline volumetric parameters and long-interval metabolic changes
Used ΔSUVmax₁₋₃ for risk stratification
Baseline volumetric parameters identified as strong prognostic markers
ΔSUVmax₁₋₃ provided additional risk stratification
Dynamic PET metrics support clinical decision-making

Abstract

Baseline volumetric parameters and long-interval metabolic changes are powerful prognostic markers in Hodgkin Lymphoma. ΔSUVmax₁₋₃ provides additional risk stratification beyond baseline measurements, supporting integration of dynamic PET metrics into clinical practice.

KI fragen

Bookmark

View Full Paper